Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients
Clinical trial NCT03734211 · COMPLETED
Trial details
- NCT number
- NCT03734211
- Sponsor
- Lars Gullestad
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-10
- Primary completion
- 2023-05-20
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.